Logo image of CRBN.AS

CORBION NV (CRBN.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:CRBN - NL0010583399 - Common Stock

18.18 EUR
-0.1 (-0.55%)
Last: 12/24/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, CRBN scores 5 out of 10 in our fundamental rating. CRBN was compared to 75 industry peers in the Chemicals industry. CRBN has only an average score on both its financial health and profitability. CRBN is valued quite cheap, but it does not seem to be growing. This makes CRBN very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CRBN was profitable.
CRBN had a positive operating cash flow in the past year.
Each year in the past 5 years CRBN has been profitable.
CRBN had a positive operating cash flow in each of the past 5 years.
CRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFCRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

With a decent Return On Assets value of 4.55%, CRBN is doing good in the industry, outperforming 68.00% of the companies in the same industry.
CRBN has a better Return On Equity (9.12%) than 66.67% of its industry peers.
With a decent Return On Invested Capital value of 9.19%, CRBN is doing good in the industry, outperforming 74.67% of the companies in the same industry.
CRBN had an Average Return On Invested Capital over the past 3 years of 6.62%. This is in line with the industry average of 7.13%.
The 3 year average ROIC (6.62%) for CRBN is below the current ROIC(9.19%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.55%
ROE 9.12%
ROIC 9.19%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
CRBN.AS Yearly ROA, ROE, ROICCRBN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

CRBN's Profit Margin of 5.11% is fine compared to the rest of the industry. CRBN outperforms 64.00% of its industry peers.
CRBN's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 8.68%, CRBN is doing good in the industry, outperforming 64.00% of the companies in the same industry.
CRBN's Operating Margin has declined in the last couple of years.
CRBN's Gross Margin of 26.10% is on the low side compared to the rest of the industry. CRBN is outperformed by 61.33% of its industry peers.
CRBN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.68%
PM (TTM) 5.11%
GM 26.1%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
CRBN.AS Yearly Profit, Operating, Gross MarginsCRBN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRBN is still creating some value.
The number of shares outstanding for CRBN has been reduced compared to 1 year ago.
Compared to 5 years ago, CRBN has less shares outstanding
CRBN has a better debt/assets ratio than last year.
CRBN.AS Yearly Shares OutstandingCRBN.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CRBN.AS Yearly Total Debt VS Total AssetsCRBN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

CRBN has an Altman-Z score of 2.73. This is not the best score and indicates that CRBN is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of CRBN (2.73) is comparable to the rest of the industry.
CRBN has a debt to FCF ratio of 4.95. This is a neutral value as CRBN would need 4.95 years to pay back of all of its debts.
CRBN has a better Debt to FCF ratio (4.95) than 73.33% of its industry peers.
A Debt/Equity ratio of 0.39 indicates that CRBN is not too dependend on debt financing.
The Debt to Equity ratio of CRBN (0.39) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.95
Altman-Z 2.73
ROIC/WACC1.43
WACC6.42%
CRBN.AS Yearly LT Debt VS Equity VS FCFCRBN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.21 indicates that CRBN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.21, CRBN is doing worse than 81.33% of the companies in the same industry.
A Quick Ratio of 0.60 indicates that CRBN may have some problems paying its short term obligations.
With a Quick ratio value of 0.60, CRBN is not doing good in the industry: 88.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.6
CRBN.AS Yearly Current Assets VS Current LiabilitesCRBN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

CRBN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.99%.
CRBN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 49.47% yearly.
CRBN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.95%.
The Revenue has been growing slightly by 5.70% on average over the past years.
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%

3.2 Future

The Earnings Per Share is expected to grow by 15.24% on average over the next years. This is quite good.
CRBN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.71% yearly.
EPS Next Y36.6%
EPS Next 2Y22.97%
EPS Next 3Y19.62%
EPS Next 5Y15.24%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRBN.AS Yearly Revenue VS EstimatesCRBN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CRBN.AS Yearly EPS VS EstimatesCRBN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

7

4. Valuation

4.1 Price/Earnings Ratio

CRBN is valuated correctly with a Price/Earnings ratio of 16.23.
Based on the Price/Earnings ratio, CRBN is valued a bit cheaper than the industry average as 72.00% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.57. CRBN is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 11.95, which indicates a very decent valuation of CRBN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRBN indicates a somewhat cheap valuation: CRBN is cheaper than 80.00% of the companies listed in the same industry.
CRBN is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.23
Fwd PE 11.95
CRBN.AS Price Earnings VS Forward Price EarningsCRBN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRBN is valued a bit cheaper than 68.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CRBN is valued cheaper than 92.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.61
EV/EBITDA 7.67
CRBN.AS Per share dataCRBN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRBN has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CRBN's earnings are expected to grow with 19.62% in the coming years.
PEG (NY)0.44
PEG (5Y)0.33
EPS Next 2Y22.97%
EPS Next 3Y19.62%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.49%, CRBN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.58, CRBN pays a bit more dividend than its industry peers.
CRBN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.88.
Industry RankSector Rank
Dividend Yield 3.49%

5.2 History

The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
CRBN.AS Yearly Dividends per shareCRBN.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

CRBN pays out 56.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of CRBN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP56.19%
EPS Next 2Y22.97%
EPS Next 3Y19.62%
CRBN.AS Yearly Income VS Free CF VS DividendCRBN.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M
CRBN.AS Dividend Payout.CRBN.AS Dividend Payout, showing the Payout Ratio.CRBN.AS Dividend Payout.PayoutRetained Earnings

CORBION NV

AMS:CRBN (12/24/2025, 7:00:00 PM)

18.18

-0.1 (-0.55%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31 2025-07-31
Earnings (Next)N/A N/A
Inst Owners90.59%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.06B
Revenue(TTM)1.30B
Net Income(TTM)66.20M
Analysts78.57
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.49%
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP56.19%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.96%
PT rev (3m)2.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.61%
Revenue NY rev (3m)-1.59%
Valuation
Industry RankSector Rank
PE 16.23
Fwd PE 11.95
P/S 0.82
P/FCF 10.61
P/OCF 6.28
P/B 1.46
P/tB 1.67
EV/EBITDA 7.67
EPS(TTM)1.12
EY6.16%
EPS(NY)1.52
Fwd EY8.37%
FCF(TTM)1.71
FCFY9.42%
OCF(TTM)2.89
OCFY15.91%
SpS22.26
BVpS12.47
TBVpS10.88
PEG (NY)0.44
PEG (5Y)0.33
Graham Number17.72
Profitability
Industry RankSector Rank
ROA 4.55%
ROE 9.12%
ROCE 10.92%
ROIC 9.19%
ROICexc 9.57%
ROICexgc 10.55%
OM 8.68%
PM (TTM) 5.11%
GM 26.1%
FCFM 7.7%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexgc growth 3Y0.82%
ROICexgc growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score6
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.95
Debt/EBITDA 1.43
Cap/Depr 81.01%
Cap/Sales 5.3%
Interest Coverage 7.03
Cash Conversion 85.4%
Profit Quality 150.76%
Current Ratio 1.21
Quick Ratio 0.6
Altman-Z 2.73
F-Score6
WACC6.42%
ROIC/WACC1.43
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
EPS Next Y36.6%
EPS Next 2Y22.97%
EPS Next 3Y19.62%
EPS Next 5Y15.24%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%
EBIT growth 1Y54.53%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year128.83%
EBIT Next 3Y37.35%
EBIT Next 5Y26.73%
FCF growth 1Y171.85%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y118.83%
OCF growth 3Y101.81%
OCF growth 5Y9.98%

CORBION NV / CRBN.AS FAQ

What is the fundamental rating for CRBN stock?

ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.


Can you provide the valuation status for CORBION NV?

ChartMill assigns a valuation rating of 7 / 10 to CORBION NV (CRBN.AS). This can be considered as Undervalued.


What is the profitability of CRBN stock?

CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CRBN stock?

The Price/Earnings (PE) ratio for CORBION NV (CRBN.AS) is 16.23 and the Price/Book (PB) ratio is 1.46.


Can you provide the dividend sustainability for CRBN stock?

The dividend rating of CORBION NV (CRBN.AS) is 6 / 10 and the dividend payout ratio is 56.19%.